Cognis Signs Exclusive Licensing Agreement with Natural ASA for Tonalin CLA.Business Editors, Health/Medical Writers DUSSELDORF, Germany--(BW HealthWire)--Aug. 15, 2002 Cognis Aims to Further Expand Tonalin(R) CLA CLA, n.pr See acid, conjugated linoleic. into Dietary Supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement , Food Ingredient, Pharmaceutical and Cosmetic Markets ("the Key Markets") Cognis, a global specialty chemicals and nutritional ingredients company, and Natural ASA Asa (ā`sə), in the Bible, king of Judah, son and successor of Abijah. He was a good king, zealous in his extirpation of idols. When Baasha of Israel took Ramah (a few miles N of Jerusalem), Asa bought the help of Benhadad of Damascus and , a Norwegian research and development company, announced today that they have signed an agreement effective Sept. 1, 2002 which grants Cognis an exclusive license in the Key Markets, under Natural's Conjugated Linoleic Acid Conjugated linoleic acid (CLA) refers to a family of many isomers of linoleic acid (at least 13 are reported), which are found primarily in the meat and dairy products of ruminants. As implied by the name, the double bonds of CLAs are conjugated. (CLA) intellectual property, technology, and know-how, and an exclusive license for the use of the Tonalin(R) trademark. Conjugated Linoleic Acid (CLA) has been shown to be a beneficial fatty acid fatty acid, any of the organic carboxylic acids present in fats and oils as esters of glycerol. Molecular weights of fatty acids vary over a wide range. The carbon skeleton of any fatty acid is unbranched. Some fatty acids are saturated, i.e. which is not synthesized by the human body and which must therefore be consumed in the diet. Tonalin(R) CLA, a well-studied, high CLA content formulation, is primarily marketed today as a dietary supplement with benefits for lean body mass management. The signing of this licensing agreement is a consequence of the Memorandum of Understanding A Memorandum of Understanding (MoU) is a legal document describing a bilateral or multilateral agreement between parties. It expresses a convergence of will between the parties, indicating an intended common line of action and may not imply a legal commitment. that was announced April 24, 2002. Natural ASA is the world's leading supplier of CLA and parent company of Natural Inc., based in Vernon Hills, Ill. Patent rights licensed exclusively to Natural from the Wisconsin Alumni Research Foundation The Wisconsin Alumni Research Foundation is the nonprofit technology transfer office of the University of Wisconsin-Madison. It is a significant source of research support, independent of federal grants. (WARF WARF Wisconsin Alumni Research Foundation WARF Wide Aperture Research Facility WARF Wartime Active Replacement Factors WARF weighted-average risk factor WARF Wartime Attrition and Replacement Factors WARF Whylie Animal Rescue Foundation ) are part of the agreement. WARF, a not-for-profit organization based in Madison, Wis., offers intellectual property management services to the faculty of the University of Wisconsin. "Cognis is committed to building the Tonalin(R) mark's excellent brand equity on a worldwide basis in the dietary supplement, food ingredient, pharmaceutical and cosmetic markets," said Paul Allen, group vice president, Cognis Nutrition and Health. "We are dedicated to funding new research and clinical studies to further develop the science for Tonalin(R) CLA in the Key Markets," added Allen. In addition to its scientific program, Cognis is planning an advertising and public relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most campaign to strengthen the Tonalin(R) brand name's visibility among consumers. This agreement is mutually advantageous for Cognis and Natural. Cognis is seeking to build its product portfolio of nature-based ingredients for a variety of markets. Natural ASA was seeking an international company operating in the relevant markets to take over the global commercial development of CLA through licensing agreements. Calling Cognis "the ideal licensing partner," Natural ASA selected Cognis for its scope of expertise in foods, dietary supplements, cosmetics and pharmaceuticals. Cognis and Natural ASA are collaborating to ensure a seamless transfer of Natural's portfolio of Tonalin(R) CLA under Cognis' Nutrition and Health Division. Cognis will assume global sales responsibility on Sept. 1, 2002. For information in North America about Tonalin(R) brand CLA after Sept. 1, call 800/673-3702 to place an order, e-mail cognis.custserv@cognis-us.com, or fax 513/482-3576. For information in Europe about Tonalin(R) brand CLA after Sept. 1, call +49-211-7940-9692, e-mail nutrition-and-health-europe@cognis.com, or fax +49-211 798-2390. For information in Asia Pacific about Tonalin(R) brand CLA after Sept. 1, call +61-3-9584-4588. In the interim, customers should continue to contact their Natural sales representative for assistance. About CLA CLA is a polyunsaturated polyunsaturated /poly·un·sat·u·rat·ed/ (-un-sach´er-at-ed) denoting a chemical compound, particularly a fatty acid, having two or more double or triple bonds in its hydrocarbon chain. , conjugated fatty acid Conjugated fatty acids are polyunsaturated fatty acids in which at least one pair of double bonds are separated by only one single bond, as follows: -C=C-C=C- See also
Natural has developed and patented a number of CLA-containing substances, and expects to see CLA used in the future for preventive medical purposes. About Cognis Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients with almost 9,100 employees in close to 50 countries all around the world. The company has dedicated its activities to a high level of sustainability and delivers natural source ingredients for food, nutrition and healthcare markets and serves major customers in the cosmetics, detergents and cleaners industries. Additionally, Cognis provides solutions for a number of industries such as coatings and inks, lubricants, textiles and plastics as well as agrosolutions and mining chemicals. Cognis is owned by the investors the Permira Funds, GS Capital Partners, and the Schroder Ventures Life Sciences Funds. In 2001, Cognis recorded sales of 3.1 billion euros and an operating profit Operating profit (or loss) Revenue from a firm's regular activities less costs and expenses and before income deductions. operating profit See operating income. of 174 million euros. About Natural Natural (www.natural.no), headquartered in Oslo, Norway, is a research and development company positioned between an external research network and the food/animal feed industries. Natural's objective is to develop high-value bioactive bi·o·ac·tive adj. Of or relating to a substance that has an effect on living tissue. bioactive having an effect on or eliciting a response from living tissue. patent-protected lipid products for licensing to global markets. The main markets are producers of animal feed, human food, and dietary supplements around the world. The research network consists of over 150 researchers connected to universities and research organizations, principally in the United States. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion